Michael Dilling

Background

About Michael Dilling

The Executive Director Commercialization, Technology Management, BCM Ventures, with responsibility for leading the licensing and intellectual property management team in BCM Ventures, Baylor College of Medicine's integrated commercialization team. Twenty one years' experience managing a team and a diverse portfolio of biomedical technologies in a leading health sciences university commercialization program with a focus on producing impactful outcomes. Strong pragmatic, principled focus on finding common ground to get deals closed and executed so that important innovations can get to the market and be developed into new products. Personally negotiated and closed over 100 license/option agreements, and have supervised hundreds more, including exclusive licenses for therapeutics, vaccine technologies, gene therapy and immunotherapy technologies, medical devices, software, research tools (knockout mice/cell lines/vectors/antibodies). A number of the exclusive licenses were transactions involving equity as part of the license consideration. etc. I have also licensed software. A number of technologies that I have licensed are now in clinical development, including a T-cell-based vaccine against multiple sclerosis, a vaccine against Norwalk and associated noroviruses, and an immunotherapeutic cancer vaccine.